Latest venBio Partners LLC Stock Portfolio

$519Million | No. of Holdings #7

venBio Partners LLC Performance

2026 Q2+13.02%
YTD+44.37%
2025+26.25%

About venBio Partners LLC and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, venBio Partners LLC reported an equity portfolio of $519.4 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of venBio Partners LLC are PHVS, , . The fund has invested 30.9% of it's portfolio in PHARVARIS N V and 27.8% of portfolio in PARABILIS MEDICINES INC. <br><br> The fund managers got completely rid off ARTIVA BIOTHERAPEUTICS INC stocks. They significantly reduced their stock positions in HARMONY BIOSCIENCES HLDGS IN (HRMY). venBio Partners LLC opened new stock positions in PARABILIS MEDICINES INC and ACHIEVE LIFE SCIENCE INC (ACHV). The fund showed a lot of confidence in some stocks as they added substantially to PHARVARIS N V (PHVS).
venBio Partners LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$519Million
  as of Aug 14, 2026

venBio Partners LLC Annual Return Estimates Vs S&P 500

Our best estimate is that venBio Partners LLC made a return of 13.02% in the last quarter. In trailing 12 months, it's portfolio return was 161.4%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
parabilis medicines inc144,150,000
achieve life science inc38,623,100

New stocks bought by venBio Partners LLC

Additions

Ticker% Inc.
pharvaris n v0.09

Additions to existing portfolio by venBio Partners LLC

Reductions

Ticker% Reduced
harmony biosciences hldgs in-3.48

venBio Partners LLC reduced stake in above stock

Sold off

Ticker$ Sold
artiva biotherapeutics inc-3,421,810

venBio Partners LLC got rid off the above stocks

Sector Distribution

venBio Partners LLC has about 83.2% of it's holdings in Others sector.

  • Others
  • Healthcare
Sector%
Others83.2
Healthcare16.8

Market Cap. Distribution

venBio Partners LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • SMALL-CAP
  • MICRO-CAP
  • MID-CAP
Category%
UNALLOCATED83.2
SMALL-CAP8.3
MICRO-CAP5.1
MID-CAP3.3

Stocks belong to which Index?

About 9.4% of the stocks held by venBio Partners LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others90.6
RUSSELL 20009.4
Top 5 Winners (%)%
HRMY
harmony biosciences hldgs in
29.5 %
alumis inc
27.7 %
PHVS
pharvaris n v
22.4 %
ALXO
alx oncology hldgs inc
3.2 %
Top 5 Winners ($)$
PHVS
pharvaris n v
29.4 M
alumis inc
27.7 M
HRMY
harmony biosciences hldgs in
4.0 M
ALXO
alx oncology hldgs inc
0.8 M
Top 5 Losers (%)%
LYEL
lyell immunopharma inc
-30.0 %
Top 5 Losers ($)$
LYEL
lyell immunopharma inc
-2.0 M

venBio Partners LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of venBio Partners LLC

venBio Partners LLC has 7 stocks in it's portfolio. LYEL proved to be the most loss making stock for the portfolio. PHVS was the most profitable stock for venBio Partners LLC last quarter.

$519.38MTotal Value
8.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of venBio Partners LLC, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
PHVS
Pharvaris N V

Pharvaris N V

PHVS
venBio Partners LLC's holding in Pharvaris N V over time
30.92%4,643,430
$160.57M
30.92%
increased 0.09 percentadded
Com
Parabilis Medicines Inc

Parabilis Medicines Inc

venBio Partners LLC's holding in Parabilis Medicines Inc over time
27.75%5,266,700
$144.15M
27.75%
new position
Com
Alumis Inc

Alumis Inc

venBio Partners LLC's holding in Alumis Inc over time
24.54%4,528,410
$127.43M
24.54%
unchanged 0 percentunchanged
Com
Artiva Biotherapeutics Inc

Artiva Biotherapeutics Inc

venBio Partners LLC's holding in Artiva Biotherapeutics Inc over time
0%0.00
$0.00
0%
decreased 100 percentsold off